Hamid Khoja insider trades

Open-market stock purchases and sales by Hamid Khoja, Chief Scientific Officer at FibroBiologics, Inc, from SEC Form 4 filings since Aug 12, 2024.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +48%.

Recent trades

DateStockTradeValue
Sep 15, 2026FBLG FibroBiologics, IncBought (not open market)$500K
Sep 15, 2026FBLG FibroBiologics, IncBought (not open market)$463K
May 4, 2026FBLG FibroBiologics, IncBought (not open market)—
Mar 4, 2026FBLG FibroBiologics, IncBought$11.4K

Companies traded

  • FBLG FibroBiologics, Inc: 3 buys, last Sep 15, 2026

Get free alerts when Hamid Khoja files a new trade →